Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03916744
Brief Title: A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

First Submitted : April 10, 2019
First Submitted that Met QC Criteria : April 12, 2019
First Posted : April 16, 2019

Last Update Submitted that Met QC Criteria : June 15, 2021
Last Update Posted : June 18, 2021